Clinical trials sponsored by Ono Pharmaceutical Co., Ltd.

Phase breakdown

Conditions studied

Recruiting trials led by Ono Pharmaceutical Co., Ltd.

• A Study of ONO-2020 in Patients With Agitation Associated With Alzheimer's Disease Dementia
  NCT06803823 · Phase: Phase 2 · Ages: 55 Years to 90 Years · Sex: All (male and female) · 38 locations
• A Study of ONO-3310 in Healthy Adult Male Subjects and Chronic Kidney Disease Patients With Type 2 Diabetes Mellitus
  NCT07619157 · Phase: Phase 1 · Ages: 18 Years to 64 Years · Sex: All (male and female) · 2 locations
• A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
  NCT06948448 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 39 locations
• A Study to Evaluate the Safety, Efficacy, and PK of ONO-2017 in Japanese Patients With POS 2 to 17 Year Olds
  NCT07594158 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · 1 location
• ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.
  NCT06579573 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · 25 locations
• Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures
  NCT06590896 · Phase: Phase 2 · Ages: No age limits stated · Sex: All (male and female) · 29 locations

Common questions

How many trials is Ono Pharmaceutical Co., Ltd. recruiting for?

Ono Pharmaceutical Co., Ltd. is the lead sponsor of 6 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.